News Focus
News Focus
icon url

Dr Speculator Ninja

01/15/13 3:50 PM

#41431 RE: dr_lowenstein #41430

This is an also ran issue. Many on the board have already addressed how those "trials" have stability issues, 60% drop out rates, previous product pulled from market...etc...etc....


icon url

Couch

01/15/13 3:52 PM

#41432 RE: dr_lowenstein #41430

Ironic that Purdue is heavily lobbying for the FDA to push their abuse resistant measures both for Branded and Generic products......and if they succeed will only help ELTP!!! Now that is funny!!! :-)
icon url

NASDAQ2020

01/15/13 4:36 PM

#41449 RE: dr_lowenstein #41430

Drop out rate may kill the trial.